BSEBoard Meeting4d ago · 14 Nov 2026, 05:22 pm
Dear Sir/Ma''am, Please find Qutcome of the Board Meeting held on 14 November, 2026 for approval of Unaudited Financial Results of the Company along with Statement of Assets and Liabilities, Cash Flow Statement and Limited Review Report for the Quarter and half year ended on 30 September, 2026.
Omkar Pharmachem Ltd · 532167
✦ AI SummaryResults
Omkar Pharmachem Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a net profit of Rs. 0.39 lakhs and a loss of Rs. 1.00 lakhs for the quarter. The company's total assets stood at Rs. 3667.59 lakhs and total liabilities at Rs. 423 lakhs.
Analysis Scores
Earnings Impact2/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Omkar Pharmachem Ltd - 532167 - Board Meeting Outcome for Outcome Of Board Meeting Held On 14.11.2026
Attachments (1)
📄pdf
Download →
4c2eef90-3bb8-46cc-848b-d4f468a567b1.pdf
View document text
| :'.3’{) Omkar Phavmachem Led.
Date: 14/11/2026
BSE Limited,
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai-400001
Sub: - Qutcome of the Board Meeting held on 14" November, 2026
Company Serip Code: 532167
Dear Sir,
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure
Requirements) Regulations 2015, please note that the Board in their meeting held on 14
November, 2026 has considered and approved the following business:
Unaudited Financial Results of the Company along with Statement of Assets and
Liabilities, Cash Flow Statement and Limited Review Report for the Quarter and half
year ended on 30" September, 2026.
The aforesaid board meeting commenced at 04:30 P.M. and concluded at 05:11 P.M.
This is for your information and record.
Thanking You,
Yours faithfully,
For Omkar Pharmachem Limited
Bhawani S Goyal
(Managing Director)
DIN: 03255804
Address: Ward No-03, Nangal Chaudhry,
Narnaul, Mahendragarh, Haryana-123023
Reg. Off.: 310, Wall Street-1, Near Gujarat College Cross Road, Ellisbridge Ahmedabad-380006, GJ, Ph.: 9711811163
CIN: L83000GJ1985PLC025276, Email: investors.opl@gmail.com, Website: www.omkarpharmachem.co.in
39 Ombkar Phavmachem Le.
Statement of Standalone Unaudited Financial Results for the Quarter and Six Months ended 30th September, 2026
(Rs. in lakhs except per share data)
Sr. Quarter Ended On Six Months Ended On | Year Ended
No Particulars On
. 30-09-2026 [30-06-2026 [30-09-2025 (30-09-2026 |30-09-2025 | 31-03-2026
(Unaudited)| (Unaudited) |(Unaudited)| (Unaudited) | (Unaudited)| (Audited)
Part-I
1|Income from operations
a)Net Sales/ Income from Operations 0.00 0.00 0.00 0.00 0.00 0.00
b)Other Operating Income 9.00 9.00 13.50 18.00 27.00 46.50
9.00! 9.00 13.50 18.00 27.00 46.50
2 |Other Income 0.00; 0.00 0.44 0.00 0.44 0.74
3 |Net Total Income 9.00 9.00 13.94; 18.00 27.44 47.24
4 |Expenses
) Cost of material consumed 0.00 0.00 0.00 0.00 0.00 0.00
b) Purchase of Stock-in-trade 0.00 0.00 0.00 0.00 0.00 0.00
) Changes in Inventories of Finished
Goods, WIP and Stock-in trade 0.00 0.00 0.00 0.00 0.00 0.00!
d) Employee benefits expenses 6.34 5.14 5.36 11.49 9.85 20.86.
¢) Finance Cost 0.00 0.00 0.21 0.00 0.21 0.21
f) Depreciation and Amortization 0.03 0.04 0.08 0.07 0.16 0.33
2) Other Expenses 2.24 4.82 149 7.06 6.84 9.56
Total Expenses 8.61 10.00 7.14 18.62 17.06 30.96
5 |Profit(Loss) from operations before
Exceptional Items & Taxes (3-4) 0.39 (1.00) 6.80 (0.62) 10.38 16.28
6 |Exceptional items: 0.00 0.00 0.00 0.00 0.00 0.00
7 |Profit(Loss) before Tax (5+6) 0.39 (1.00) 6.80 (0.62) 10.38 16.28
8 |Tax Expense 0.00 0.00 1.73 0.00 264 4.10
9 | Profit(Loss) for the period (7-8) 0.39 (1.00) 5.07 (0.62) 7.74 1218
10 {Other Comprehensive Income 0.00 0.00 0.00 0.00 0.00 2708.43
11 |Total Comprehensive Income for the
period (9+10) 0.39 (1.00)’ 5.07 (0.62) 7.74 2720.61
12 [Paid up Equity Share Capital (Face
Value Rs. 10/-each) 1008.37 1008.37, 1008.37 1008.37 1008.37 1008.37
13 [Other Equity
| B E | (52.82)
14 |Earning Per Share(before & after
extraordinary items)(of Rs. 10
each)(not annualised) Basic and
diluted Rs. 0.0039 (0.0099) 0.0503 (0.0061) 0.0768 0.1208
Reg. Off.; 310, Wall Street-1, Near Gujarat College Cross Road, Ellisbridge Ahmedabad-380006, GJ, Ph.: 9711811163
CIN: L93000GJ1995PLC025276, Email: investors. opl@gmail.com, Website: www.omkarpharmachem.co.in
39 Owmkar Phavmachem Led.
| Statement of Assets and Liabilities as at 30th September, 2026 (Rs. in lakhs)
| . Asat30-09-2026 Asat31-03-2026
| Particulars (Unaudited) (Audited)
| ASSETS
Non-current Assets
| a) Property, plant and equipment 0.30 037
b) Capital work-in-progress 0.00 0.00
<) Goodwill on consolidation 0.00 0.00
4) Other intangible asscts 0.00 0.00
<) Intangible assets under development 0.00 0.00
1 Financial asscts 0.00 0.00
1) Investments
a) Investment in associate 0.00 0.00
b) Investments in joint ventures 0.00 0.00
¢) Other Investments 3638.43 3638.43
ii) Other Financial Asscts 0.00 0.00
) Deferred tax assets (net) 0.10 010
h Other non current assets 0.00 0.00
| Total Non-current Assets 3638.83 3638.90
Current Asscts
a) Inventorics 0.00 0.00
b) Financial asscs
i) Other Investments 0.00 0.00
ii) Trade receivables 6.48 324
i) Cash and cash cquivalents 1647 2173
iv) Bank balances other than iii) above 0.00 0.00
V) Other financial assets 0.00 0.00
) Other current assets 581 5.17]
| Total Current Assets 28.76 30.14,
Total Assets 3667.59 3669.04
EQUITY AND LIABILITIES
Equity
) Equity share capital 1008.37 100837
b) Other cquity : Reserve and Surplus 265499 2655.61
Equity attributable to the owners of the company 3663.36 3663 98
Non-controlling interests 0.00 0.00)
Total Equity 3663.36 3663.98
Non-current libilitics
Financial liabiltics
a) Borrowings 0.00 0.00
b) Provisions 0.00 0.00
) Deferred tax liabilities(Net) 0.00 0.00
Total Non-current Liabilities 0.00 0.00
Current Liabilities
a) Financial liabilities
i) Borrowings 0.00 0.00
ii) Trade Payables 1.00 0.71
iii) Other fianncial liabilities 0.00 0.00
b) Provisions 0.00 0.00
©) Other current liabilities 323 4.35
Total-current Liabilitics 423 5.06
Total Liabil 423 5.06
[Total Equity and Liabilities 3667.59 3669.04
Reg. Off.: 310, Wall Street-1, Near Gujarat College Cross Road, Ellisbridge Ahmedabad-380006, GJ, Ph.: 97118 11163
: L93000GJ1995PLC025276, Email: investors.opl@gmailWe.bcsoimte,: www.omkarpharmachem.co.in
39 Owmkar Phavmachem L&
Unaudited Cash flow statement for the half year ended on 30th September, 2026 (Rs. in lakhs)
Half year ended IHalf year ended
30th September, 2026 30th September, 2025
A. CASH FLOW FROM OPERATING ACTIVITIES
Net profit before tax and exceptional items (0.62) 10.38
Adjustment For :
Depreciation 0.07 0.16
Net interest paid (received) 0.00 0.21
Operating profit before working capital change (055) 1075
Adjustment For :
Trade and other receivables (3.24)) 0.00
Other current assets (0.64)] @271
Trade and other payable 029 (0.23)
Other current liabilities (1.12) 0.72)
Cash Generated from operation (5.26). 7.09
Cash flow before extra ordinary items 0.00 0.00
(Less) IncomeTaxPaid including AdvanceTax/TDS less refund 0.00 0.00
NET CASH FLOW FROM OPERATING ACTIVITIES (5.26)] 7.09
B. CASH FLOW FROM INVESTING ACTIVITIES
Sale of Property, plant and equipment (Land) 0.00 0.00
Sale of Investment 0.00 0.00
Purchase of Property, plant and equipment 0.00 0.00
NET CASH USED IN INVESTING ACTIVITIES 0.00 0.00
C. CASH FLOW FROM FINANCIAL ACTIVITIES
Interest received/(paid) 0.00 ©21)
Short Term Borrowings 0.00 (11.85)
NET CASH FLOW FROM FINANCIAL ACTIVITIES 0.00 (12.06)
TOTAL CASH FLOW (5.26)) (4.97)]
NET INCREASE/DECREASE IN CASH AND CASH EQUIVALENTS
Opening Cash and Cash Equivalents 2173 10.94
Closing Cash and Cash Equivalents 1647 597
NET INCREASE/DECREASE IN CASH AND CASH EQUIVALENTS (5.26) (4.97)
Notes
1. The above results have been reviewed by the Audit committee & approved by the Board of Directors at their respective mecting
held on 14-11-2026
2. Corrosponding previous period figures are regrouped/rearranged whercever necessary, to make them comparable.
3. The Financial Result for the Quarter and Half ycar ended on 30-09-2026 has been prepared in accordance with IND-AS specified under section
133 of the Companies Act and rules made thereunder.
4. The IND-AS regarding segment reporting is not applicable to the company.
By order (71 mc@a‘m
(Bhawani S Goyal)
Managing Director.
DIN No. 03255804
Date : 14-11-2026
F Ward No- 03, Nangal Chaudhry, Narnaul,
Place: Ahmedabad
T Mahendragarh, Haryana-123023
Reg. Off.: 310, Wall Street-1, Near Gujarat College Cross Road, Ellisbridge Ahmedabad-380006, GJ, Ph.: 9711811163
CIN: L83000GJ1995PLC025276, Email: investors.opl@gmail.com, Website: www.omkarpharmachem.co.in
M‘|D RSC RELSE naco.
507, Mauryansh Elanza, Nr. Parekhs Hospital, Shyamal Cross Road, Road,
Emall: info@drscindia.com
TRUST | ETHICS| kNOWLEDGE Satdlite Anmadabad - 380 015. (M) 94093 68999 (0) 079 - 40053654 Web : www.drscindia.com
Limited Review Report to the Board of
[Showing first 8,000 characters — download PDF for full document]